Steven J. Schnell

Steven J. Schnell is a seasoned scientist with extensive experience in laboratory operations and management across various biotechnology companies. Currently serving as Senior Scientist and Laboratory Operations Manager at Aprea Therapeutics, Steven has successfully facilitated the transition of laboratory operations during the company's evolution into a publicly-traded organization. In an interim role at Proteovant Therapeutics, Steven is involved in scaling up laboratory operations in the protein degradation sector. Previous positions include contributions as a Scientific Consultant and Senior Scientist at IO Biosciences, where Steven developed groundbreaking genetic cell modification technologies. With a robust background as a Research Scientist and Laboratory Manager at Temple University and prior roles at Charles River Laboratories as a Study Coordinator and Quality Assurance Auditor, Steven holds a PhD in Developmental Biology from Temple University.